Lung mass medical therapy

Jump to navigation Jump to search

Lung Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Lung Mass from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Diagnosis

Diagnostic Study of Choice

Evaluation of Lung Mass

Imaging of Lung Mass

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Lung mass medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lung mass medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lung mass medical therapy

CDC on Lung mass medical therapy

Lung mass medical therapy in the news

Blogs on Lung mass medical therapy

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Lung mass medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:

Overview

Medical Therapy

Medical therapy for patients with lung mass vary and depends upon the underlying histology and staging.

  • Patients with Small Cell Carcinoma are treated with chemotherapy. Small cell carcinoma generally present at an advanced stage where surgery is not advisable and hence treated with chemotherapy.
  • Patients with Non-Small Cell Carcinoma (NSCC), are treated with surgical resection whenever surgery is advisable.